These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3130490
1. Effect of fibronectin-rich human cryoprecipitate on fluid volume requirements in sheep during postoperative sepsis. Holman JM, Saba TM, Lewis E. J Trauma; 1988 May; 28(5):571-81. PubMed ID: 3130490 [Abstract] [Full Text] [Related]
2. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies. Saba TM, Niehaus GD, Scovill WA, Blumenstock FA, Newell JC, Holman J, Powers SR. Ann Surg; 1983 Nov; 198(5):654-62. PubMed ID: 6416192 [Abstract] [Full Text] [Related]
3. Lung fluid and protein flux during postoperative sepsis. Holman JM, Saba TM, Niehaus GD, Lewis E. Circ Shock; 1985 Nov; 17(2):121-36. PubMed ID: 4053299 [Abstract] [Full Text] [Related]
4. Lung matrix incorporation of plasma fibronectin reduces vascular permeability in postsurgical bacteremia. Resnikoff M, Brien T, Vincent PA, Rotundo RF, Lewis E, McKeown-Longo PJ, Saba TM. Am J Physiol; 1999 Oct; 277(4):L749-59. PubMed ID: 10516216 [Abstract] [Full Text] [Related]
5. Fibronectin in severe sepsis. Stevens LE, Clemmer TP, Laub RM, Miya F, Robbins L. Surg Gynecol Obstet; 1986 Mar; 162(3):222-8. PubMed ID: 3082023 [Abstract] [Full Text] [Related]
6. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations. Saba TM, Blumenstock FA, Shah DM, Landaburu RH, Hrinda ME, Deno DC, Holman JM, Cho E, Dayton C, Cardarelli PM. Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437 [Abstract] [Full Text] [Related]
7. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference? Su F, Wang Z, Cai Y, Rogiers P, Vincent JL. Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457 [Abstract] [Full Text] [Related]
8. Incorporation of circulating fibronectin into various tissues during sepsis: colocalization with endogenous tissue fibronectin. Jin HM, Vincent PA, Charash WE, Saba TM, McKeown-Longo P, Blumenstock FA, Lewis E. Exp Mol Pathol; 1991 Dec; 55(3):203-16. PubMed ID: 1748211 [Abstract] [Full Text] [Related]
9. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate. Hesselvik F, Brodin B, Blombäck M, Cedergren B, Lieden G, Maller R. Scand J Clin Lab Invest Suppl; 1985 Dec; 178():67-74. PubMed ID: 3937220 [Abstract] [Full Text] [Related]
10. Plasma fibronectin levels in clinical disease states and after cryoprecipitate infusion. Ragni MV, Lewis JH, Spero JA, Bontempo FA. Thromb Haemost; 1984 Dec 29; 52(3):321-4. PubMed ID: 6442471 [Abstract] [Full Text] [Related]
11. Plasma fibronectin therapy and lung protein clearance with bacteremia after surgery. Cohler LF, Saba TM, Lewis E, Vincent PA, Charash WE. J Appl Physiol (1985); 1987 Aug 29; 63(2):623-33. PubMed ID: 3654422 [Abstract] [Full Text] [Related]